Investing.com - Smith & Wesson (NASDAQ: SWBI) reported first quarter EPS of $-0.02, $0.21 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $86.68M versus the consensus estimate of $129.78M.
Smith & Wesson's stock price closed at $14.19. It is down -12.73% in the last 3 months and up 35.01% in the last 12 months.
Smith & Wesson saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Smith & Wesson's stock price’s past reactions to earnings here.
According to InvestingPro, Smith & Wesson's Financial Health score is "fair performance".
Check out Smith & Wesson's recent earnings performance, and Smith & Wesson's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.